111. Immunological effects of BRAF+MEK inhibition. (2nd September 2018) Authors: Ascierto, Paolo A.; Dummer, Reinhard Journal: Oncoimmunology Issue: Volume 7:Number 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
112. Integrating first-line treatment options into clinical practice: what's new in advanced melanoma?. Issue 6 (December 2015) Authors: Dummer, Reinhard; Schadendorf, Dirk; Ascierto, Paolo A.; Larkin, James; Lebbé, Celeste; Hauschild, Axel Journal: Melanoma research Issue: Volume 25:Issue 6(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
113. Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapy. (November 2021) Authors: Dimitriou, Florentia; Hogan, Sabrina; Menzies, Alexander M.; Dummer, Reinhard; Long, Georgina V. Journal: European journal of cancer Issue: Volume 157(2021) Page Start: 214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
114. Interstitial granulomatous dermatitis during talimogen laherparepvec treatment. Issue 4 (August 2017) Authors: Frauchiger, Anna L.; Brüggen, Marie-Charlotte; Goldinger, Simone M.; Dummer, Reinhard Journal: Melanoma research Issue: Volume 27:Issue 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
115. Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update. (2nd September 2019) Authors: Ramelyte, Egle; Dummer, Reinhard; Guenova, Emmanuella Journal: Expert opinion on investigational drugs Issue: Volume 28:Number 9(2019) Page Start: 799 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
116. Is single versus combination therapy problematic in the treatment of cutaneous melanoma?. Issue 1 (2nd January 2021) Authors: Krattinger, Regina; Ramelyte, Egle; Dornbierer, Joëlle; Dummer, Reinhard Journal: Expert review of clinical pharmacology Issue: Volume 14:Issue 1(2021) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
117. Laudatio zum 80. Geburtstag von Herrn Prof. Dr. med. Dr. h.c. Günter Burg. (11th March 2021) Authors: Dummer, Reinhard Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 19:Number 3(2021) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
118. Less can be more: the impact of chemotherapy on cutaneous T-cell lymphomas. (August 2013) Authors: Dummer, Reinhard; Rozati, Sima; Guenova, Emmanuella; Cozzio, Antonio Journal: Future oncology Issue: Volume 9:Number 8(2013) Page Start: 1061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
119. Less can be more: the impact of chemotherapy on cutaneous T-cell lymphomas. (August 2013) Authors: Dummer, Reinhard; Rozati, Sima; Guenova, Emmanuella; Cozzio, Antonio Journal: Future oncology Issue: Volume 9:Number 8(2013) Page Start: 1061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
120. Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB–III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity. (March 2016) Authors: Eggermont, Alexander M.M.; Suciu, Stefan; Rutkowski, Piotr; Kruit, Willem H.; Punt, Cornelis J.; Dummer, Reinhard; Salès, François; Keilholz, Ulrich; de Schaetzen, Gaetan; Testori, Alessandro Journal: European journal of cancer Issue: Volume 55(2016) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗